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Introduction
The autoinflammatory syndromes are a newly recog-
nized group of immune disorders that lack the high
titers of self-reactive antibodies and T cells characteristic
of classic autoimmune disease. , patients with these ill-
nesses experience unprovoked inflammatory disease in
the absence of underlying infection.(Curr Top Microbiol
Immunol. 2006;305:127-60).
In the category of autoinflamation this disease is a a
lesion particularly known as CRMO or chronic recur-
rent mutifocal osteomylitis a rare condition in which
bones have an lesion, inflammation and pain but with-
out a focus of infection .the result of its inheritance pat-
tern is still being debated and the distinguishing feature
from the autoimmune pattern is still not clear.
It is classified as an auto inflammatory disease due to
its recurrent out breaks and lack of any known patho-
gen.this disease tends to range from 4 to 14 years of age
and 10 years as median. As by current statistics it occur
1:1000000 and primarly in girls with a 5:1 ratio.
CRMO may similar to a painful bone lesion such as
arthritis , RF , bacterial osteomylitis ,ewings sarcoma,
lymphoma, eosinophilic granuloma or LAH. When all
the prevoious illness are ruled out and a bone biopsy
turns negative for any known cancer CRMO is usually
diagnosed.
As such the common medication given for reducing
the inflammation are such as NSAIDS and steroids,
antibiotics are not prescribed as there is no evident
focus of infection. Congenital dyserthropoitic anaemia
and CRMO , uncommon childhood diseases an associa-
tion with sweet syndrome may be interelated .(journal
of paediatrics 115 (5, part 1):730-4. Dol10.1016/S0022-
3476(89)80650.
A retrospective review of autoinflamatory diseases in
Saudi children at rheumatology clinic showed that of
the 34 children with a mean age 118 months , consan-
guinity was present in 40 %. And in which FMF 50%,
CRMO 23.5%, EOS 8.8%, MWS 6 %.(Ann Saudi med .
2012 ;32(1);43-8(ISSN;0975-4466).
CRMO is sometimes associated with palmoplantar
pustulosis and frequent relapses may be present with
remission lasting for 4-16 weeks. The most distal case if
the affected series . classical Xray diagnosis reveled ske-
letal changes consistent with appearance of acute or
chronic heamoatogenic osteomylits.morphologically
CRMO begins as an acute inflammatory process either
predominance of PMN leucocytes, with occasionally
form absesses and osteoclastic bone resorption. At a
later stage it may present as lymphocytes and inflama-
toty infiltrate and occasional granulomatous foci and
signs of new bone formation.
Case report
The pathological basis of the inflammation in the var-
ious inflammatory foci of bone lesions without the exact
non infectious cause is much debated part in the patho-
genesis of chronic recurrent multifocal osteomylitis and
the recurrent attacks that are caused may be due to an
inherent autoimmune part of the disease in the body.Pediatrics, SAT Hospital, Medical College Trivandrum, Kerala, India
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To identify the pathophysiological cause of the recur-
rent inflammatory attacks on the bone with due consid-
eration to the time period of each attack.
The specific treatment stratergy is presently soley
based on steroid therapy and the judicious use of
NSAIDs for each specific attack that is manifested there-
fore the need to design a protocol for the treatment of
recurrent attacks so as to include immunomodulators in
the list may be helpful in remission.
Method
Study design
A prospective cohort study with a chance of reverting
back to double blinded Randomized control trial in due
course may be considered.
Study setting
SAT Hospital Trivandrum and a proposed teritiary care
setting where the translational research could undertaken.
Study period
18 May 2011 – Ongoing.
Study subjects
A part from the patient , the specific disease has shown
to have a familial inheritance pattern, so the genotypic
variance along with a pedigree analysis is mandatory in
establishing the pathophysiological cause ,so the near
and distant family members might be also a part in as
study subjectsA semistructured questionare was devised
at the onset of study and progress of the disease is cur-
rently documented.
Results
The brief outline of the natural history is being given as
below. The patient of 9 years was brought to the ortho-
paedic Opd with first episode of recurrent pain and red-
ness in the joint of the third interphalengial joint and in
the knee joint of the upper tibia and the preliminary
investigation done as of which is done in the teritiary
care hospital . the routine Xray showed very well cir-
cumscribed callus around the lesion and the dull scler-
osing opacities around the joint after which the it as
subjected to open wide excision and sent for HP analy-
sis. The result first showed inflammatory infiltrate and
features suggestive of auto immune condition, it was
also sent for AFB culture result of which came as
negative.
On the provisional basis it was first diagnosis as garres
osteomylitis but features of surrounding or well circum-
scribed marginal sclerosing lesions were present and as
of which therapy was given with local antibiotics , the
recurrent attacks in the due course made the the patient
get refferd to pediatric OPD on complete review on an
immunological basis . the ANA profile was done but the
only sight fluctuations were seen in the markers. HLAB
27 was also performed which came as negative , rest of
the immunological studies are currently proceded. The
contrast enhanced MRI showe the features of suggestive
of CRMO. As subjected to the low socioeconomic status
of the patient higher investigations are pending, the cur-
rent presisting symptom that the patient complain is the
recurrent attacks of pain in at the lesion site. The two
sites ie, the head of humerus and the and the tip of ole-
cranon was not subjected to biopsy as it would hamper
the epiphysial growth. The detailed presenting history,
clinical examination, lab investigations and status of the
subject cannot be revealed at present as the patient is
only subjected to waiver of consent. As CRMO is diag-
nosis of Exclusion the next investigation most preferably
would be A TPMT assay, laser cut biopsy of the speci-
men and detailed immunohistochemistry. the provi-
sional diagnosis made were JIA, Chronic Non bacterial
osteomylitis, Non Monogenic AIDs, systemic onsent of
other autoimmune disease.
Discussion
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